METOCLOPRAMIDE

Generic: METOCLOPRAMIDE

Teva Pharmaceuticals USAManufacturer
ORALRoute
METOCLOPRAMIDE HYDROCHLORIDEActive Substance
1993-06-15Original Approval

METOCLOPRAMIDE is FDA application ANDA072801, sponsored by TEVA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-05-23
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb,

Presence of foreign tablets/capsules.

Class II2021-02-10
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC 0703-4502-01), packaged in 25 x 2 mL Single

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance le

Class II2021-04-26
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvin

Lack of Assurance of Sterility

Class II2026-10-06
Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany,

Manufacturer is recalling batches due to co-mingled tablet.

Class II2026-09-29
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Par

Presence of Foreign Tablets/Capsules

Class II2013-09-24
Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest, IL, 60

Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were

Class II2026-10-06
Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus,

Presence of Foreign Tablets/Capsules

Class II2021-02-15
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceutica

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Class II2021-07-29
Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine,

Lack of Assurance of Sterility

Top Reported Reactions

1
TARDIVE DYSKINESIA
15,392 reports
2
EXTRAPYRAMIDAL DISORDER
12,516 reports
3
NERVOUS SYSTEM DISORDER
7,404 reports
4
DYSTONIA
6,998 reports
5
PAIN
5,063 reports
6
NAUSEA
4,879 reports
7
ECONOMIC PROBLEM
3,808 reports
8
VOMITING
3,746 reports
9
ANXIETY
3,352 reports
10
DIARRHOEA
3,304 reports